Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
AB-729, a GalNAc-siRNA, results in robust reductions of HBV DNA and HBsAg in subjects with chronic hepatitis B infection Proceeding/Conference:Hepatology International | 2021 |
